Safety of a 1-hour Rule-out High-sensitive Troponin T Protocol in Patients With Chest Pain at the Emergency Department

Autor: S. De Vries-Spithoven, Judith M. Poldervaart, Arno W. Hoes, Johannes B. Reitsma, C. E.E. Van Ofwegen-Hanekamp, A. Limburg, E. Röttger
Rok vydání: 2017
Předmět:
Adult
Male
Chest Pain
medicine.medical_specialty
Acute coronary syndrome
Time Factors
Adolescent
medicine.medical_treatment
Acute coronary syndromes
030204 cardiovascular system & hematology
Chest pain
Diagnosis
Differential

Electrocardiography
Young Adult
03 medical and health sciences
0302 clinical medicine
Troponin T
Internal medicine
medicine
Humans
Acute chest pain
Prospective Studies
Rule-out protocol
cardiovascular diseases
030212 general & internal medicine
Myocardial infarction
Major adverse cardiac events
Aged
biology
business.industry
Unstable angina
Percutaneous coronary intervention
Emergency department
Middle Aged
medicine.disease
Troponin
High-sensitivity cardiac troponin t
ROC Curve
Cardiology
biology.protein
Female
medicine.symptom
Emergency Service
Hospital

Cardiology and Cardiovascular Medicine
business
Biomarkers
Mace
Zdroj: Critical Pathways in Cardiology, 16(4), 129. Lippincott Williams and Wilkins
ISSN: 1535-282X
Popis: Background The 1-hour rule-out high-sensitive cardiac troponin T protocol (hs-cTnT), in which a serial troponin measurement is performed 1 hour after the first to assess the possibility of acute coronary syndrome (ACS), has been implemented in the European guidelines in 2015. Our aim was to assess the safety of this protocol in low-risk patients in the Emergency Department (ED) when implemented in daily practice. Methods Patients with acute chest pain presenting to the ED of our hospital and younger than 75 years were included (May 2013 to October 2014, The Netherlands). Hs-cTnT was measured at presentation (T0) and 1-1.5 hours after T0 (T1). Patients with a first troponin (T0) ≥ 0.012 ug/l were excluded. Primary endpoint was the 6-week occurrence of major adverse cardiac events (MACEs), defined as unstable angina, acute myocardial infarction (AMI), percutaneous coronary intervention, significant stenosis managed conservatively, coronary artery bypass grafting, and death. Results Of the 374 analyzed patients, 16 patients (4.3%) developed 35 MACE. Of these 16 patients with endpoints, 3 were primarily discharged with noncardiac chest pain but returned within 6 weeks with unstable angina. Importantly, no patients experienced an AMI or died during follow-up. Conclusion No AMIs or deaths occurred after introducing the 1-hour hs-cTnT protocol to rule-out ACS in chest pain patients, but other MACE such as unstable angina occurred. Our results suggest the protocol is safe to implement in the ED in The Netherlands.
Databáze: OpenAIRE